Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps

Rik J. L. van der Lans; Josje J. Otten; Gwijde F. J. P. M. Adriaensen; Linda B. L. Benoist; Marjolein E. Cornet; D. Rienk Hoven; Albert B. Rinia; Wytske J. Fokkens; Sietze Reitsma

doi:10.4193/Rhin23.081

Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps

Rik J. L. van der Lans, Josje J. Otten, Gwijde F. J. P. M. Adriaensen, Linda B. L. Benoist, Marjolein E. Cornet, D. Rienk Hoven, Albert B. Rinia, Wytske J. Fokkens, Sietze Reitsma^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	383-384
Number of pages	2
Journal	Rhinology
Volume	62
Issue number	3
DOIs	https://doi.org/10.4193/Rhin23.081
Publication status	Published - 2024

Access to Document

10.4193/Rhin23.081

Cite this

van der Lans, R. J. L., Otten, J. J., Adriaensen, G. F. J. P. M., Benoist, L. B. L., Cornet, M. E., Hoven, D. R., Rinia, A. B., Fokkens, W. J., & Reitsma, S. (2024). Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps. Rhinology, 62(3), 383-384. https://doi.org/10.4193/Rhin23.081

@article{86a45d1e5bdf41c5a08d9e83ce54e59e,

title = "Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps",

author = "\{van der Lans\}, \{Rik J. L.\} and Otten, \{Josje J.\} and Adriaensen, \{Gwijde F. J. P. M.\} and Benoist, \{Linda B. L.\} and Cornet, \{Marjolein E.\} and Hoven, \{D. Rienk\} and Rinia, \{Albert B.\} and Fokkens, \{Wytske J.\} and Sietze Reitsma",

year = "2024",

doi = "10.4193/Rhin23.081",

language = "English",

volume = "62",

pages = "383--384",

journal = "Rhinology",

issn = "0300-0729",

publisher = "University Hospital Utrecht",

number = "3",

}

Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps. / van der Lans, Rik J. L.; Otten, Josje J.; Adriaensen, Gwijde F. J. P. M. et al.
In: Rhinology, Vol. 62, No. 3, 2024, p. 383-384.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps

AU - van der Lans, Rik J. L.

AU - Otten, Josje J.

AU - Adriaensen, Gwijde F. J. P. M.

AU - Benoist, Linda B. L.

AU - Cornet, Marjolein E.

AU - Hoven, D. Rienk

AU - Rinia, Albert B.

AU - Fokkens, Wytske J.

AU - Reitsma, Sietze

PY - 2024

Y1 - 2024

UR - http://www.scopus.com/inward/record.url?scp=85195328201&partnerID=8YFLogxK

U2 - 10.4193/Rhin23.081

DO - 10.4193/Rhin23.081

M3 - Comment/Letter to the editor

C2 - 38478151

SN - 0300-0729

VL - 62

SP - 383

EP - 384

JO - Rhinology

JF - Rhinology

IS - 3

ER -

Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps

Access to Document

Other files and links

Cite this